Treatment of Newly Diagnosed Peripheral T-cell Lymphoma
NCT03631862
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Newly Diagnosed Peripheral T-cell Lymphoma
Interventions
DRUG:
Apatinib
DRUG:
CHOP Regimen
Sponsor
Zhengzhou University